glp 1 agonist full form Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic GLP-1 Agonists - FAQ —

Ease of connecting with quality providers

Diabetes Metab Syndr Obes (2020) 13:307587

Cardiovascular and renal outcomes with empagliflozin in heart failure

Lancet (2017)

The clinical trials included in the review had a high degree of heterogeneity in terms of substance types, patients' characteristics, and types and doses of the administered GLP-1 receptor agonists

49 Further evaluation on a double-blind, randomized phase 1 clinical trial in 98 patients with T2DM on current management with metformin revealed that Danuglipron was generally well tolerated and associated with minimal side effects such as nausea, dyspepsia, and vomiting comparable with the ones observed with the use of injectable GLP-1RA